32.79
  Price1.52%   +0.49
(After Hours: 32.70 -0.0900 -0.27%)
Jun-15-21 10:24AM Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021Benzinga
Jun-11-21 05:50AM Invitae (NVTA) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research
Jun-08-21 03:46AM Why Invitae Was Down 17.5% in MayThe Motley Fool
Jun-07-21 07:11AM What's the Best Way to Invest in Genetics Stocks?The Motley Fool
Jun-04-21 12:55PM This Biotech Just Made History. Will Its Stock Follow?The Motley Fool
08:37AM 2 Winners for a Drug Development Future That Looks Nothing Like the PastThe Motley Fool
Jun-02-21 12:55PM Invitae: Dilution Is Stunting ShareholdersSeeking Alpha
May-29-21 06:10AM Can Invitae Be the Winner-Take-Most in Genetic Testing?The Motley Fool
May-27-21 09:01AM Here's the Top Takeaway for Healthcare Investors Right NowThe Motley Fool
May-13-21 06:16AM 3 Cathie Wood Stocks for a $150 Billion Market That's Just FormingThe Motley Fool
06:04AM Here's What Stood Out With Invitae's Q1 ResultsThe Motley Fool
May-11-21 09:15AM NASDAQ Drops More Than 2.5% to Begin WeekZacks Investment Research
May-07-21 05:50AM Invitae (NVTA) Outpaces Stock Market Gains: What You Should KnowZacks
May-05-21 09:53AM Invitae Shares Trading Lower As Q1 Earnings Lag Estimates, Contracting MarginsBenzinga
03:31AM Invitae (NVTA) Q1 2021 Earnings Call TranscriptMotley Fool
May-04-21 06:55AM Invitae (NVTA) Reports Q1 Loss, Tops Revenue EstimatesZacks
06:09AM Shares of Cancer Researchers Exact Sciences and Invitae Are Sliding. Here’s Why.Barrons.com
May-04-21 04:05AM Invitae Reports $103.6 Million in Revenue Driven by 259,000 in Billable Volume in First Quarter of 2021PR Newswire
Apr-29-21 09:04AM Invitae (NVTA) to Report Q1 Earnings: What's in the Offing?Zacks
Apr-28-21 05:50AM Invitae (NVTA) Dips More Than Broader Markets: What You Should KnowZacks
Apr-23-21 08:59AM Moving Average Crossover Alert: Invitae Corp (NVTA)Zacks
Apr-22-21 05:50AM Invitae (NVTA) Stock Moves -0.39%: What You Should KnowZacks
Apr-20-21 04:05AM Invitae to Open New Facility in North Carolina to Support Continued GrowthPR Newswire
07:30AM Invitae to Announce First Quarter 2021 Financial Results on Tuesday, May 4, 2021PR Newswire
Apr-19-21 10:00AM AstraZeneca, Loxo Oncology at Lilly, and Invitae Corporation Join the Access to Comprehensive Genomic Profiling CoalitionPR Newswire
Apr-17-21 07:15AM Is Invitae a Buy?Motley Fool
06:20AM 1 Number That Should Shock Fulgent Genetics InvestorsMotley Fool
Apr-15-21 07:30AM Study finds risk-causing genetic changes in nearly 1 in 6 patients with colorectal cancerPR Newswire
Apr-14-21 05:50AM Invitae (NVTA) Dips More Than Broader Markets: What You Should KnowZacks
Apr-13-21 05:08AM Do Institutions Own Invitae Corporation (NYSE:NVTA) Shares?Simply Wall St.
Apr-12-21 07:26AM How a Simple Blood Test Could Reduce Cancer DeathsBarrons.com
Apr-10-21 06:40AM 3 Top Healthcare Stocks to Buy in AprilMotley Fool
Apr-08-21 08:24AM How a Simple Blood Test Could Reduce Cancer DeathsBarrons.com
07:30AM Invitae joins NIH-sponsored study aimed at improving understanding of the links between genes and cancer, heart disease and other conditionsPR Newswire
Apr-08-21 06:45AM How a Simple Blood Test Could Bend the Cancer Mortality CurveBarrons.com
Apr-07-21 08:55AM Is NVTA Stock A Buy or Sell?Insider Monkey
Apr-05-21 09:37AM SoftBank to Lead $1.2 Billion Investment in Invitae, Reports Dow JonesBloomberg
09:29AM Invitae Accelerates Personalized Oncology Testing With Genosity AcquisitionBenzinga
Apr-05-21 07:56AM UPDATE 1-SoftBank to lead nearly $1.2 bln investment in diagnostics firm InvitaeReuters
07:43AM SoftBank to lead nearly $1.2 billion investment in diagnostics firm InvitaeReuters
Apr-05-21 07:30AM Invitae to acquire Genosity to accelerate access to personalized oncology testing worldwidePR Newswire
06:59AM Invitae Shares Are Trading Higher On SoftBank's Potential $1.2B Debt Investment: WSJBenzinga
Apr-05-21 06:08AM Invitae Surges as SoftBank Leads $1.15 Billion InvestmentTheStreet.com
Apr-01-21 07:30AM Invitae introduces new program to increase access to genetic testing for adult neurodegenerative conditionsPR Newswire
Mar-31-21 07:45AM 3 Top Artificial Intelligence Stocks to Buy in AprilMotley Fool
Mar-26-21 05:50AM Invitae (NVTA) Stock Sinks As Market Gains: What You Should KnowZacks
Mar-24-21 03:29AM Why Invitae Stock Tumbled TodayMotley Fool
Mar-19-21 06:01AM Is This Underappreciated Cathie Wood Stock a Better Buy Than Tesla Right Now?Motley Fool
Mar-13-21 07:01AM How Do Fulgent Genetics and Invitae Stack Up Against Each Other?Motley Fool
Mar-11-21 03:15AM Why Invitae Stock Jumped TodayMotley Fool
Invitae Corporation, a genetic information company, processes DNA-containing samples, analyzes information related to patient-specific genetic variation, and generates test reports for clinicians and their patients in the United States, Canada, and internationally. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders, and other hereditary conditions; proactive health and wellness screening; and preimplantation embryo testing and carrier screening for inherited disorders, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. It also operates Patient Insights Networks, a platform for collecting, curating, coordinating, and delivering data from patients and clinicians; and CancerGene Connect, an end-to-end platform that is used for the collection, analysis, and management of patient family history information. Invitae Corporation serves patients, healthcare providers, and biopharma and advocacy partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
Cap:    |  Volume (24h):